Literature DB >> 30737544

Does Drug-Eluting Bead TACE Enhance the Local Effect of IRE? Imaging and Histopathological Evaluation in a Porcine Model.

Peter Isfort1, Philip Rauen2, Hong-Sik Na2, Nobutake Ito2, Saskia von Stillfried2, Christiane Kuhl2, Philipp Bruners2.   

Abstract

OBJECTIVES: We conducted an in vivo trial on swine to compare the ablation volumes of irreversible electroporation (IRE) followed by drug-eluting beads transarterial chemoembolization (DEB-TACE) versus IRE only.
MATERIALS AND METHODS: Nine swine underwent CT-guided IRE in one liver lobe and IRE immediately followed by DEB-TACE in a different liver lobe. For DEB-TACE, 100-300 µm beads (DC-Beads®) were loaded with 50 mg doxorubicin. For IRE, the NanoKnife® was used employing two electrodes according to the vendor's protocol. Imaging follow-up was performed including CT-based lesion volume assessment using contrast-enhanced CT (venous phase) on days 1, 3, and 7 after the procedure. Three animals were killed for histopathological analysis after each follow-up.
RESULTS: Ablation volumes in CT in the IRE + DEB-TACE group were 15.4 ± 10.5 ml on day 1, 8.7 ± 5.6 ml on day 3, and 1.6 ± 0.7 ml on day 7. In the IRE group, the corresponding values were 5.2 ± 5.2 ml on day 1, 1.0 ± 1.2 ml on day 3, and 0.1 ± 0.1 ml on day 7. On day 1 and day 3, ablation volumes of IRE + TACE group were significantly larger than in the IRE group (p < 0.05). 96% of beads were depicted in or around ablative lesions. 69% of these beads were found in the surrounding hemorrhagic infiltration and 31% within the ablative lesion itself.
CONCLUSIONS: Combination of IRE immediately followed by DEB-TACE resulted in larger ablation volumes compared to IRE alone, suggesting that local efficacy of IRE can be enhanced by post-IRE DEB-TACE.

Entities:  

Keywords:  Drug-eluting bead TACE; Experimental study; Hepatocellular carcinoma; Irreversible electroporation; Transarterial chemoembolization

Mesh:

Year:  2019        PMID: 30737544     DOI: 10.1007/s00270-019-02181-1

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

Review 1.  Ablation plus Transarterial Embolic Therapy for Hepatocellular Carcinoma Larger than 3 cm: Science, Evidence, and Future Directions.

Authors:  Andrew R Lewis; Carlos A Padula; J Mark McKinney; Beau B Toskich
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

2.  Combination of irreversible electroporation with sustained release of a synthetic membranolytic polymer for enhanced cancer cell killing.

Authors:  Samuel M Hanson; Bruce Forsyth; Chun Wang
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

3.  Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma.

Authors:  Kai-Cai Liu; Wei-Fu Lv; Dong Lu; Chang-Long Hou; Jun Xie; Yu-He Lu; Qi-Sheng Cao; Yu-Lin Tan; Ying-Zhan Zhang; Jie Liu
Journal:  Cancer Manag Res       Date:  2021-10-19       Impact factor: 3.989

Review 4.  Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?

Authors:  Evgenia Kotsifa; Chrysovalantis Vergadis; Michael Vailas; Nikolaos Machairas; Stylianos Kykalos; Christos Damaskos; Nikolaos Garmpis; Georgios D Lianos; Dimitrios Schizas
Journal:  J Pers Med       Date:  2022-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.